In this review the current aspects concerning the application of leukocytapheresis in patients
with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been …

Leukocytapheresis, a blood purification therapy, exerts anti-inflammatory effects by
removing activated leukocytes from the peripheral blood through extracorporeal circulation …

Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

Intense infiltration of the intestinal mucosa by activated leukocytes is a hallmark of
inflammatory bowel disease (IBD). Therefore, removal of circulating leukocytes may be an …

Apheresis systems have been used in inflammatory bowel disease with a view to
immunomodulation. The technique employs a system of white cell extraction, filtration and …

This article presents information on inflammatory bowel diseases. The principal concept of
leukocytapheresis therapy is based on the removal of activated leukocytes from the …

Leukocytapheresis has reemerged as a novel “nondrug” approach in the treatment of
inflammatory bowel disease. The technique involves the extracorporeal passage of …

Studies about leukocytapheresis have emerged with the need of search for alternatives to
conventional treatment in inflammatory bowel diseases (IBD). Leukocytapheresis is a novel …

Leukocyte apheresis works by purifying distinct populations of active leukocytes and by
modifying inflammatory mediators. Based on their theoretical immunomodulatory effect …

Inflammatory bowel disease is characterized by clinical remission and relapse caused by
severe intestinal inflammation. Drug therapy for inflammatory bowel disease is associated …